OMCL
Omnicell, Inc.Healthcare · $1.5B market cap
Verdict
Share price
$33.60
close of Oct 3, 2026
Fair value
$29.32
Sticker Price
Payback Price
$11.73
buy price
OMCL is Overpriced: at $33.60 it trades 15% above its fair value of $29.32. Its buy price (Payback Price) is $11.73, 65% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Justified P/B (Financials). It has earned a steady return on its equity for years, and its tangible assets are worth 17% of its share price. For a business like that, book value and the return on it are a sturdier guide than an earnings forecast.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow OMCL
Get notified when it reaches its buy price of $11.73. Free.
Create a free accountInsider activity
Since Jul 1, 2026: no open-market purchases, 2 sales worth $584K and 5 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Other filings
Manley Corey J
EVP&CHIEF LEGAL/ADMIN OFFICER · 2026-08-15
Tax withholding
$150K
LIPPS RANDALL A
CHAIRMAN, CEO · 2026-08-15
Tax withholding
$461K
Njoku Nnamdi
President & COO · 2026-08-15
Tax withholding
$137K
NUTT BRIAN H.
VP, Chief Accounting Officer · 2026-08-15
Tax withholding
$35K
Njoku Nnamdi
President & COO · 2026-07-01
Award
12,309 shares
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication…
Medical - Healthcare Information Services
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works